News Posts List

Georgia State Spin-Off, Inlighta Biosciences LLC, Receives $2 Million Grant To Develop Enhanced MRI Contrast Agents For Liver Cancers And Metastasis


ATLANTA—A local start-up, life sciences company founded by Dr. Jenny Yang, Regents’ Professor of Biochemistry at Georgia State University, has received a $2 million federal grant to develop improved magnetic resonance imaging (MRI) contrast agents for the early detection of liver cancers and other cancers, such as uveal melanoma or eye cancer, that have metastasized to the liver.

GeoVax Awarded NIH Grant for Zika Vaccine


GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant of $600,000 in support of its novel Zika vaccine development program.

Quest Diagnostics to Form Precision Oncology Center of Excellence Through Acquisition of Two Texas..


MADISON, N.J., June 12, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) today announced that it has signed definitive agreements to acquire two laboratory businesses in Lewisville, Texas, with the aim to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients nationwide.

Vertera Spine raises $3.1 million


Atlanta-based Vertera Spine Inc. raised more than $3 million, according to documents filed with the U.S. Securities and Exchange Commission. The company, located at 739 Trabert Avenue Northwest, began raising money Feb. 7.

New chair named for Coulter Department of Biomedical Engineering


Susan Margulies, PhD, has been named the Wallace H. Coulter Chair of the Coulter Department of Biomedical Engineering (BME) at Georgia Tech and Emory University, and a Georgia Research Alliance Eminent Scholar in Injury Biomechanics. Her appointments are effective August 1.

Aziyo Continues Building New Breed of Regenerative Medicine Company


SILVER SPRING, MD. – Aziyo Biologics, Inc. a fully integrated regenerative medicine company, today announced it has completed an asset purchase agreement with CorMatrix® Cardiovascular, Inc. for the purchase of all CorMatrix commercial assets and related intellectual property.

Georgia State Researcher Receives $7.7 Million Federal Grant To Study West Nile And Zika Viruses


ATLANTA—A Georgia State University researcher, in collaboration with researchers at the University of Pennsylvania and Florida State University, has received a five-year, $7.7 million federal grant to study the consequences of West Nile and Zika virus infections on the human central nervous system.

National Institutes Of Health $2.3 Million Renewal Grant To Study Enzyme In Diabetic Vascular Disease


ATLANTA—Dr. Ming-Hui Zou, director of the Center for Molecular & Translational Medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine, has renewed a four-year, $2.3 million federal grant to study the role of an enzyme in causing diabetic vascular diseases and the molecular mechanism that leads to these diseases.

Cocrystal Pharma Receives Investment Through Private Placement


BOTHELL, WA and ATLANTA, GA -- (Marketwired) -- 04/24/17 -- On April 20, 2017, Cocrystal Pharma, Inc. (OTCQB: COCP) (the "Company") closed on proceeds of $3,000,000 in a private placement offering (the "Offering") of 12,500,000 shares of the Company's common stock at a purchase price of $0.24 per share. The purchasers included one of the members of the Company's board of directors, Chairman Dr. Raymond F. Schinazi. In addition, OPKO Health, Inc. invested in the Offering, of which the Company's director Dr. Phillip Frost is Chairman and Chief Executive Officer.

ATDC Names Michael Maziar Investor Relations Manager


The Advanced Technology Development Center, Georgia’s technology incubator, has named Michael Maziar investor relations manager. Maziar, who had been chief operations officer of Atlanta Technology Angels, will manage ATDC’s Investor Connect program and its related activities, as well as develop and maintain relationships with angels, venture capitalists, and other sources of debt and equity financing for ATDC’s portfolio companies.

Previous  |  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  Next